Replimune Group Inc (NASDAQ:REPL) shares, rose in value on Wednesday, July 09, with the stock price up by 11.24% to the previous day’s close as strong demand from buyers drove the stock to $10.39.
Actively observing the price movement in the last trading, the stock closed the session at $9.34, falling within a range of $9.4 and $10.41. The value of beta (5-year monthly) was 0.612. Referring to stock’s 52-week performance, its high was $17.00, and the low was $6.44. On the whole, REPL has fluctuated by 0.10% over the past month.
With the market capitalization of Replimune Group Inc currently standing at about $800.93 million, investors are eagerly awaiting this quarter’s results, scheduled for on 2025-May-22.
Technical indicators serve as essential tools for traders, offering insights into market sentiment and potential price movements. We see that REPL’s technical picture suggests that short-term indicators denote the stock is a Hold on average. However, medium-term indicators have put the stock in the category of 50% Sell while long-term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the price of REPL currently trading nearly 8.42% and 14.27% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 62.20, while the 7-day volatility ratio is showing 6.86% which for the 30-day chart, stands at 5.87%. Furthermore, Replimune Group Inc (REPL)’s beta value is 0.69.
A comparison of Replimune Group Inc (REPL) with its peers suggests the former has fared considerably weaker in the market. REPL showed an intraday change of 11.24% in last session, and over the past year, it shrunk by -14.20%%.
Data on historical trading for Replimune Group Inc (NASDAQ:REPL) indicates that the trading volumes over the past 10 days have averaged 1.45 and over the past 3 months, they’ve averaged 1.25 million. According to company’s latest data on outstanding shares, there are 77.09 million shares outstanding.
Nearly 18.88% of Replimune Group Inc’s shares belong to company insiders and institutional investors own 93.96% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 9.32 million shares as on 2025-06-13, resulting in a short ratio of 6.54. According to the data, the short interest in Replimune Group Inc (REPL) stood at 1668.00 of shares outstanding as of 2025-06-13; the number of short shares registered in 2025-05-15 reached 9.22 million. The stock has risen by 28.11% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the REPL stock heading into the next quarter.
